The history of blood product use, and relevant clinical and product information are documented in the patient’s healthcare record to minimise risks and optimise clinical outcomes. How does the health service organisation ensure that a comprehensive history of blood product use, transfusion history, optimising a patient’s own blood and assessing the patient’s bleeding risk are documented in the patient’s healthcare record? What processes are used to document adverse reactions to blood or blood products in the patient’s healthcare record?
A pre-stransfusion bedside checklist that incorporates the ‘Fast Facts’ information about the new blood pack labels. Download
The decision to transfuse and the consideration of other blood management strategies, must be based on a thorough clinical assessment of the patient and of that person’s individual needs. The indication for transfusion or other blood management strategies must be documented in the patient’s healthcare record. All blood transfusions must have a valid informed consent. It can be provided by the patient, parent or legal guardian, or follow the emergency medical procedure consent protocols. A conversation about the reasons for transfusion and expectations of clinical outcomes must take place between the clinician and the patient or guardian. Any information provided should be in line with the patient or guardian’s literacy level and in a way they can understand. Consent must be documented in the patient’s medical record and/or on a transfusion-specific consent form in accordance with local health service policy. Refer to your local health service policy regarding consent processes for blood transfusion, including inability to obtain consent and for patients who refuse. All elements of the consent process should be aligned to local, State or territory and national requirements.
Always obtain and document consent from your patient. Check your local institutional guidelines about informed consent. Always cover the following when acquiring informed consent: ExplainCause/likelihood of bleeding or the low blood count (including any uncertainty). Nature of the proposed transfusion therapy—what is involved. Benefits expected. Risks common and rare but serious. Alternatives, including the risk of doing nothing. AskIs there anything else you would like to know? Is there anything you do not understand? ProvideInterpreter for non-English speaking patients. Written information.
Data from the UK Serious Hazards of Transfusion (SHOT) initiative (http://www.shotuk.org) show that around 1 in 13 000 blood units are administered to the wrong patient with occasional fatal outcomes. ‘Wrong blood into patient’ incidents are preventable and nearly always caused by human error. The root cause of most incidents is misidentification at the time of pre-transfusion blood sampling, laboratory testing, collecting the blood component from the blood bank or administration of the transfusion at the bedside. Potentially fatal ABO-incompatible transfusions still occur although improved clinical policies, staff training and introduction of methods to improve identification, resulting from the various Better Blood Transfusion initiatives, has significantly reduced their number over the last decade. Avoiding unnecessary or inappropriate transfusions is an essential starting point for safe transfusion practice. The British Committee for Standards in Haematology (BCSH) Guideline on the Administration of Blood Components (2009) (https://b-s-h.org.uk) describes the essentials of safe requesting, collection and administration of blood components (summarised in Table 4.1) and should form the basis of local transfusion policies. The key principles that underpin every stage of the blood administration process are:
Last updated 01/04/2020 |